Comment on ‘Context, not class, may be the key signal in systemic JAK inhibitor exposure in MF/SS’: reply from authors

Clicks: 15
ID: 317217
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #381 of 415 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 415 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The effects of systemic JAKis exposure in MF/SS appear context dependent and should not be interpreted as a homogeneous entity. Although disease worsening was observed in several patients initially diagnosed with presumed inflammatory dermatoses, causality cannot necessarily be inferred and may reflect, among other factors, underlying MF/SS biology, referral bias, or concurrent immunosuppressive influences. In post-transplant MF/SS patients receiving JAKis for graft-versus-host disease, MF/SS progression may reflect impaired immune surveillance or other disease-related factors rather than a direct effect of JAKis. These findings underscore the complexity of interpreting JAKi exposure in MF/SS and highlight the need for prospective studies to better define risks across clinical settings.
Reference Key
openalex_W7164651457 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag240
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.